Schizophrenia Clinical Trial
— ProActiveSOfficial title:
Testing an Intervention to Increase Physical Activity in Schizophrenia: A Feasibility and Acceptability Study.
Verified date | April 2018 |
Source | University of Edinburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
People with schizophrenia die approximately 20 years earlier than those in the general
population, and this is mostly due to cardiovascular disease (CVD) and related poor physical
health. The risk factors for CVD are significantly more prevalent in people with
schizophrenia, but they are largely preventable by, for example, engaging in regular PA.
Existing interventions to increase PA in schizophrenia are generally atheoretical and lack
manualisation and appropriate evaluation, thus reducing their usefulness to clinical
practice.
Drawing on the MRC Guidelines for the development and evaluation of complex interventions, a
12-week intervention was developed and informed by a systematic review of the factors that
influence PA in people with schizophrenia and a qualitative study exploring the barriers and
motivators to PA (n=10). The feasibility and acceptability of the intervention was then
investigated in an uncontrolled pilot study (n=20).
The pilot study demonstrated that the intervention was both feasible and acceptable to people
with schizophrenia. The retention rate was 90% (n=18), and reasons given for dropout were
work commitments and other illness.
Of the 18 who completed the intervention, 17 (94%) increased their weekly step count, 14
(78%) met current public health guidelines of 10,000 steps per day at some point during the
12 weeks, 10 (56%) experienced some weight loss, 12 (67%) took up an additional health
promotion opportunity (e.g., improving diet, stopping smoking, joining a gym) and 13 (72%)
took up another form of PA in addition to walking (e.g., swimming).
Participants found the intervention enjoyable and thought it should be offered to everyone
with schizophrenia. The intervention also proved to be feasible and acceptable to staff who
referred patients to take part. Informal feedback from staff confirmed the need for such a
service, particularly for those taking anti-psychotic medication, and indicated that, if it
was to be implemented more widely, it would be a popular and useful resource.
Status | Completed |
Enrollment | 20 |
Est. completion date | August 31, 2016 |
Est. primary completion date | August 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of schizophrenia or related disorder (e.g., schizoaffective disorder, psychosis) - Living in the community - Clinically stable for at least 8 weeks prior to intervention enrolment - Ability to safely walk unaided Exclusion Criteria: - Inability to provide informed consent |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | Chief Scientist Office of the Scottish Government, NHS Lothian |
McNamee L, Mead G, MacGillivray S, Lawrie SM. Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry. 2013 Sep;203(3):239-41. doi: 10.1192/bjp.bp.112.125070. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility and acceptability of the intervention. | Feasibility and acceptability of the intervention was evaluated using mixed-methods to explore recruitment, delivery, reasons for drop-out, participant feedback (positive and negative), and suggestions for improvement. This was quantitatively assessed by recording the number of eligible participants that agreed to participate and the number of participants that enrolled but dropped out. Participants were also asked to complete a feedback form, which contained space for free text, during the last session of the intervention. | Post intervention (12 weeks). | |
Secondary | Change in weekly step count. | Activity was measured objectively using accelerometers. | At baseline and at intervention end point (12 weeks). | |
Secondary | Change in activity levels. | Participants used their pedometers to measure daily step count and record totals in their activity diaries. Participants also recorded sedentary time in their activity diaries. | Throughout the 12-week intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |